Literature DB >> 11096573

Hemochromatosis.

.   

Abstract

The mainstay of treatment for hemochromatosis is therapeutic phlebotomy. The procedure is safe, effective, and relatively cheap. Deferoxamine (iron chelation) is necessary only in iron-loaded individuals who cannot undergo therapeutic phlebotomy. If therapy is initiated before complications develop, it is expected that no complications will ever develop.

Entities:  

Year:  1999        PMID： 11096573     DOI： 10.1007/s11938-999-0019-0

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN： 1092-8472


  3 in total

1.  A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis.

Authors:  J N Feder; A Gnirke; W Thomas; Z Tsuchihashi; D A Ruddy; A Basava; F Dormishian; R Domingo; M C Ellis; A Fullan; L M Hinton; N L Jones; B E Kimmel; G S Kronmal; P Lauer; V K Lee; D B Loeb; F A Mapa; E McClelland; N C Meyer; G A Mintier; N Moeller; T Moore; E Morikang; C E Prass; L Quintana; S M Starnes; R C Schatzman; K J Brunke; D T Drayna; N J Risch; B R Bacon; R K Wolff
Journal:  Nat Genet       Date:  1996-08       Impact factor: 38.330

Review 2.  Diagnosis and management of hemochromatosis.

Authors:  B R Bacon
Journal:  Gastroenterology       Date:  1997-09       Impact factor: 22.682

3.  Hereditary hemochromatosis: presentation and diagnosis in the 1990s.

Authors:  B R Bacon; S A Sadiq
Journal:  Am J Gastroenterol       Date:  1997-05       Impact factor: 10.864
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.